Gardener's Dream Cream
Natural health product licensed in Canada
- Licence holder
- Aroma Crystal Therapy
- NPN or DIN-HM
- 80025370
- Status
- Active licence
- Licence date
- 18 May 2011
- Revision date
- Not provided
- Form
- Crème
- Route of administration
- Topique
- Application type
- Officinale
Oral dose analysis does not apply without an established exclusively oral route.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source |
|---|---|
| 5-méthyl-2-(1-méthyléthyl)phénol Source : Plante(s) entière | 0.1255 % |
| 5-méthyl-2-(1-méthyléthyl)phénol Source : Thymol | 0.1255 % |
Non-medicinal ingredients
Acétate de d-alpha tocophéryle, Cire d'abeille jaune, Triglycéride caprylique/caprique, Acide isostéarique, Huile d'écorce de Cinnamomum Zeylanicum, Extrait de racine d'Hydrastis canadensis (Hydraste), Beurre de karité, Extrait de cannelle, Alcool cétéarylique, Eau purifiée, Lavande, Huile essentielle de romarin, Palmitate de rétinyle, Extrait de Rosmarinus Officinalis, Huile de graine d'Helianthus annuus (Tournesol), Extrait de graine de Citrus grandis (Pamplemousse), Extrait floral de Lavandula Angustifolia (Lavande), Extrait de feuilles d'Origanum Vulgare (origan), Extrait de fleur d'Arnica montana, Huile de pépin de raisin
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes, adolescents et enfants | minimum: 2 years | Not specified | Not specified |
Uses authorised in Canada
Temporarily relieves aches and pains of muscles and joints associated with one or more of the following: simple backache, lumbago, strains and sprains (involving muscles, tendons, and/or ligaments), and arthritis.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Keep out of the reach of children. If overdose or accidental ingestion occurs, call a Poison Control Center immediately. Discontinue use and consult a health care practitioner if symptoms persist and/or worsen after 7 days or re-occur within a few days.
Source
Official Health Canada record, licence 80025370
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.